Profile
Full Name
NexImmune, Inc.Ticker Symbol
NEXIExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
February 12, 2021Indexes
Not includedWebsite
http://www.neximmune.comEmployees
6Key Details
Price
$0.00(0.00%)
Market cap
$139.47(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$30.82(+52.55% YoY)
PE ratio
-
Next earnings date
May 20, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
NexImmune doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Nov 16, 22 Cantor Fitzgerald
NeutralNov 15, 22 Raymond James
Market PerformAug 16, 22 Raymond James
OutperformAug 16, 22 Barclays
OverweightJun 1, 22 BTIG
BuyApr 1, 22 Barclays
OverweightFeb 22, 22 Raymond James
OutperformNov 15, 21 Raymond James
OutperformApr 1, 21 Raymond James
OutperformMar 9, 21 Cantor Fitzgerald
OverweightInstitutional Ownership
- What is the ticker symbol for NexImmune?
- Does NexImmune pay dividends?
- What sector is NexImmune in?
- What industry is NexImmune in?
- What country is NexImmune based in?
- When did NexImmune go public?
- Is NexImmune in the S&P 500?
- Is NexImmune in the NASDAQ 100?
- Is NexImmune in the Dow Jones?
- When was NexImmune's last earnings report?
- When does NexImmune report earnings?
- Should I buy NexImmune stock now?
What is the ticker symbol for NexImmune?
The ticker symbol for NexImmune is NASDAQ:NEXI
Does NexImmune pay dividends?
No, NexImmune does not pay dividends
What sector is NexImmune in?
NexImmune is in the Healthcare sector
What industry is NexImmune in?
NexImmune is in the Biotechnology industry
What country is NexImmune based in?
NexImmune is headquartered in United States
When did NexImmune go public?
NexImmune's initial public offering (IPO) was on February 12, 2021
Is NexImmune in the S&P 500?
No, NexImmune is not included in the S&P 500 index
Is NexImmune in the NASDAQ 100?
No, NexImmune is not included in the NASDAQ 100 index
Is NexImmune in the Dow Jones?
No, NexImmune is not included in the Dow Jones index
When was NexImmune's last earnings report?
NexImmune's most recent earnings report was on Aug 7, 2024
When does NexImmune report earnings?
The next expected earnings date for NexImmune is May 20, 2025
Should I buy NexImmune stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions